Allstate Corporation’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,930
| Closed | -$545K | – | 433 |
|
|
2025
Q1 | $545K | Buy |
4,930
+2,021
| +69% | +$224K | 0.02% | 487 |
|
|
2024
Q4 | $397K | Buy |
+2,909
| New | +$397K | 0.01% | 539 |
|
|
2023
Q1 | – | Sell |
-4,215
| Closed | -$503K | – | 443 |
|
|
2022
Q4 | $503K | Buy |
4,215
+1
| +0% | +$119 | 0.02% | 495 |
|
|
2022
Q3 | $448K | Buy |
4,214
+623
| +17% | +$66.2K | 0.01% | 518 |
|
|
2022
Q2 | $350K | Buy |
+3,591
| New | +$350K | 0.01% | 556 |
|
|
2021
Q4 | – | Sell |
-3,522
| Closed | -$338K | – | 754 |
|
|
2021
Q3 | $338K | Sell |
3,522
-271
| -7% | -$26K | 0.01% | 601 |
|
|
2021
Q2 | $369K | Buy |
3,793
+250
| +7% | +$24.3K | 0.01% | 600 |
|
|
2021
Q1 | $345K | Sell |
3,543
-1,201
| -25% | -$117K | 0.01% | 638 |
|
|
2020
Q4 | $455K | Buy |
4,744
+1,323
| +39% | +$127K | 0.01% | 536 |
|
|
2020
Q3 | $329K | Sell |
3,421
-592
| -15% | -$56.9K | 0.01% | 546 |
|
|
2020
Q2 | $490K | Sell |
4,013
-172
| -4% | -$21K | 0.02% | 442 |
|
|
2020
Q1 | $362K | Sell |
4,185
-8,800
| -68% | -$761K | 0.01% | 438 |
|
|
2019
Q4 | $1.4M | Hold |
12,985
| – | – | 0.03% | 373 |
|
|
2019
Q3 | $1.17M | Buy |
12,985
+210
| +2% | +$18.9K | 0.02% | 371 |
|
|
2019
Q2 | $1.08M | Buy |
+12,775
| New | +$1.08M | 0.02% | 380 |
|